Promising market, but China’s DTC genetic testing startups have to first overcome a few hurdles

Genetic information is being used for everything from predicting health risks to personalizing exercise and dietary regimes. China represents a huge potential market for direct-to-consumer (DTC) genetic testing

In 2017, more than 15 million US consumers had their DNA analyzed through direct-to-consumer (DTC) genetic testing. The number was about 300,000 in China, a market penetration rate of only 0.03%.

Over 200 genetic testing startups have sprung up in China the past few years, including 23mofang, WeGene and Somur. And VC firms are chomping at the bit to get in on the action. In 2016, 95% of Chinese genomic startups received more than RMB 10 million in financing each.

However, in order to exploit fully the potential of the market, these startups have some significant obstacles to surmount.

For the majority of Chinese consumers, DTC genetic testing is still a technological novelty. Since the results are not accepted by hospitals for use in diagnosis and treatment, many consumers just get tested for fun. “[Many of] our customers are interested in their ethnic roots,” said 23mofang founder and CEO

To continue reading, please download the full report.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

By accessing and using www.compasslist.com and all pages within the domain (the “Website”), You accept and agree to have read, understood, accepted and agreed to be bound by the Terms of Use and Privacy Policy in full. If you disagree with all or any part of these Terms of Use and Privacy Policy, please do not use or continue any further use of this website. You acknowledge that you are aware that this Website contains an archive of existing content as at 31 December 2021 and is not being actively managed. We are under no obligation to update the content on this Website and, accordingly, no new content or articles will be posted to the Website after 31 December 2021.